Botulinum Toxin Type A Reconstituted with Lidocaine: A Report of 1000 Consecutive Cases
(1) Background: There is an increasing demand for a reversal of the aging process and, nowadays, more patients are seeking minimally invasive methods instead of surgery to meet this goal. The purpose of this paper is to evaluate the predictability of the off-label aesthetic use of botulinum toxin ty...
Main Authors: | Pierfrancesco Bove, Vincenzo Santillo, Giuseppe Colella, Rita Vitagliano, Romolo Fragola, Giorgio Lo Giudice, Nicola Zerbinati, Ivo Ferrieri, Raffaele Rauso |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/11/10/4491 |
Similar Items
-
Biphasic Injection for Masseter Muscle Reduction with Botulinum Toxin
by: Fabrizio Chirico, et al.
Published: (2021-07-01) -
Pain Control during the Treatment of Primary Palmar Hyperhidrosis with Botulinum Toxin A by a Topical Application of Liposomal Lidocaine: Clinical Effectiveness
by: Andrea Marani, et al.
Published: (2024-01-01) -
Recurrent seizures after lidocaine ingestion
by: Hamed Aminiahidashti, et al.
Published: (2015-01-01) -
Open-Label Adhesion Performance Studies of a New Lidocaine Topical System 1.8% versus Lidocaine Patches 5% and Lidocaine Medicated Plaster 5% in Healthy Subjects
by: Gudin J, et al.
Published: (2021-02-01) -
Lidocaine infusion for the treatment of burn pain: A review of recent updates
by: Attia Attia, et al.
Published: (2022-10-01)